Inhibrx Biosciences Inc (INBX)
15.45
-1.13
(-6.82%)
USD |
NASDAQ |
Nov 13, 16:00
15.56
+0.10
(+0.68%)
After-Hours: 20:00
Inhibrx Biosciences Market Cap: 223.65M for Nov. 13, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2024 | 223.65M |
| November 12, 2024 | 240.01M |
| November 11, 2024 | 231.61M |
| November 08, 2024 | 234.65M |
| November 07, 2024 | 235.38M |
| November 06, 2024 | 232.34M |
| November 05, 2024 | 227.42M |
| November 04, 2024 | 225.10M |
| November 01, 2024 | 228.72M |
| October 31, 2024 | 232.05M |
| October 30, 2024 | 235.81M |
| October 29, 2024 | 233.06M |
| October 28, 2024 | 231.61M |
| October 25, 2024 | 222.49M |
| October 24, 2024 | 222.49M |
| October 23, 2024 | 228.14M |
| October 22, 2024 | 228.72M |
| October 21, 2024 | 224.38M |
| October 18, 2024 | 231.61M |
| October 17, 2024 | 234.08M |
| October 16, 2024 | 232.34M |
| October 15, 2024 | 227.85M |
| October 14, 2024 | 224.38M |
| October 11, 2024 | 226.40M |
| October 10, 2024 | 225.53M |
| Date | Value |
|---|---|
| October 09, 2024 | 226.84M |
| October 08, 2024 | 231.47M |
| October 07, 2024 | 221.05M |
| October 04, 2024 | 213.66M |
| October 03, 2024 | 215.40M |
| October 02, 2024 | 222.93M |
| October 01, 2024 | 223.65M |
| September 30, 2024 | 226.69M |
| September 27, 2024 | 224.67M |
| September 26, 2024 | 221.92M |
| September 25, 2024 | 223.22M |
| September 24, 2024 | 224.38M |
| September 23, 2024 | 226.84M |
| September 20, 2024 | 235.67M |
| September 19, 2024 | 253.18M |
| September 18, 2024 | 245.95M |
| September 17, 2024 | 249.28M |
| September 16, 2024 | 252.31M |
| September 13, 2024 | 237.55M |
| September 12, 2024 | 218.30M |
| September 11, 2024 | 217.14M |
| September 10, 2024 | 219.74M |
| September 09, 2024 | 220.03M |
| September 06, 2024 | 218.01M |
| September 05, 2024 | 232.19M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
159.81M
Minimum
Aug 09 2024
260.86M
Maximum
Jun 03 2024
214.47M
Average
219.89M
Median
Market Cap Benchmarks
| CEL-SCI Corp | 38.75M |
| AIM ImmunoTech Inc | 15.32M |
| IGC Pharma Inc | 27.77M |
| NovaBay Pharmaceuticals Inc | 3.481M |
| Protalix BioTherapeutics Inc | 91.19M |
Market Cap Related Metrics
| PE Ratio | 0.1333 |
| Price to Book Value | 1.020 |
| Price | 15.45 |
| Earnings Yield | 750.4% |